At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 60 enrolled
Drug / intervention
Mechanical Thrombectomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Thrombectomy REvascularization of Large Vessel Occlusions in Acute Ischemic Stroke (TREVO)
In Brief
A Phase 4 clinical trial evaluating Mechanical Thrombectomy for Ischemic Stroke. Completed, enrolled 60 participants across 7 sites in 4 countries.
Detailed Summary
To determine the revascularization rate of the CE-marked Trevo device in large vessel occlusions in ischemic stroke patients. * Revascularization, defined as at least TICI 2a in the vascular territory treated at end of the neuro interventional procedure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIschemic Stroke
CountriesAustria, Germany, Spain, Sweden
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2010
First PostedMar 2010
Primary CompletionAug 2011
Study CompletionNov 2011
TodayJul 2026
First PostedMar 17, 2010
Enrollment StartFeb 1, 2010
Primary CompletionAug 1, 2011
Study CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 16.3 years ago
Interventions
Mechanical Thrombectomyprocedure
The Trevo device is intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke.